NC // Decision Intelligence powered by Claim Forensics

Know when the record to reassess a claim is still moving.

Evidence often stabilizes before institutions formally act. We identify the evidence patterns that materially change the read—so you can reassess while the window is still open.

For strategy, HEOR, and commercial leads: know when new evidence has stabilized—and whether your current position has become dangerous to maintain. Delivered as a 1-page decision brief.

One Claim To Reassess
One Decision Safety / Regulatory
Window Status Open / Closing

01 // THE PROBLEM

New evidence arrives before you reassess.

Evidence stabilizes before institutions formally update. By identifying specific stability signals, we identify when new evidence has become too settled to ignore—and when the evidence record is still moving.

We show what holds, what is contested, and what evidence shifts would change the call.

When this matters:

  • Safety signal emergence
  • Regulatory label updates
  • Guideline language shifts
  • Medical affairs field readiness
  • Post-marketing surveillance reviews

02 // THE OUTPUT

A reassessment brief your team can forward to leadership.

Each brief answers: Can this claim still be challenged, and how much time do we have?

Window status (Open / Narrowing / Closing), what holds, what is under stress, what would reverse the read, and a suggested action envelope for your reassessment strategy.

1-Page Decision Brief For Safety / Regulatory / Medical Affairs
  • Window Status: Open / Narrowing / Closing
  • What Changed: Trajectory of evidence shifts
  • What Holds: Stable evidence supporting the read
  • What Is Under Stress: Contested evidence points
  • What Would Reverse: Reversal conditions
Trust Boundary

We do not predict outcomes. We show what is stable, what is contested, and what would change the call.

Start

Have a claim whose defensibility just changed?

Send the claim, the decision date, and what new evidence arrived. We respond within one business day with fit, limits, and whether the window to reassess is still open.

Requests require a verified institutional email address and are subject to current measurement scope.

Today's Read finerenone-cardiorenal
Hardening
Signal 0.38 / Gate 0.65
Phase 1b pending review. Other lanes: dossier-build.

Visual Debug

Page:

Width: px

Theme: